Lipella PharmaceuticalsLIPO
13F holders, Q4 2024 (December 31)3holders
$3.08avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Lipella Pharmaceuticals Inc. (LIPO) in their 13F filings. The largest holders were Virtu Financial LLC ($41K), MAI Capital Management ($382) and Bank of America Corp. ($21).
- Company
- Lipella Pharmaceuticals Inc.
- CUSIP
- 53630L209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $41K |
| Exits | 0 | $0 |
Ownership 3 holders
| Virtu Financial LLC | 0.00% | New | 13,310 | $41K |
| MAI Capital Management | 0.00% | New | 125 | $382 |
| Bank of America Corp. | 0.00% | New | 7 | $21 |
"% of holder's portfolio" is LIPO's weight in each manager's 13F, not the share of Lipella Pharmaceuticals Inc. the manager owns.